Comparison of salivary beta-defensin-1 levels in patients with periodontitis before and after phase I periodontal therapy

Background. This study compared human β-defensin 1 (hBD-1) salivary levels in patients with periodontitis before and after phase I periodontal therapy. Methods. This controlled before-and-after study included 16 patients in the intervention group and 28 participants in the control group. Patients in...

Full description

Saved in:
Bibliographic Details
Main Authors: Somaye Ansari Moghadam, Sina Pishadast, Leila Gholami, Ebrahim Alijani, Alireza Ansari Moghadam, Mahdi Hadilou
Format: Article
Language:English
Published: Tabriz University of Medical Sciences 2024-05-01
Series:Journal of Advanced Periodontology and Implant Dentistry
Subjects:
Online Access:https://japid.tbzmed.ac.ir/PDF/japid-16-30.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850062105923813376
author Somaye Ansari Moghadam
Sina Pishadast
Leila Gholami
Ebrahim Alijani
Alireza Ansari Moghadam
Mahdi Hadilou
author_facet Somaye Ansari Moghadam
Sina Pishadast
Leila Gholami
Ebrahim Alijani
Alireza Ansari Moghadam
Mahdi Hadilou
author_sort Somaye Ansari Moghadam
collection DOAJ
description Background. This study compared human β-defensin 1 (hBD-1) salivary levels in patients with periodontitis before and after phase I periodontal therapy. Methods. This controlled before-and-after study included 16 patients in the intervention group and 28 participants in the control group. Patients in the intervention group had stage 3 grade B periodontitis with no systemic diseases and had not taken any medications in the last six months. The control group included participants with healthy periodontium. Before and after phase I periodontal therapy, salivary samples were collected from the intervention group. ELISA was used to measure hBD-1 levels. Results. Salivary levels of hBD-1 decreased after phase I periodontal treatment in periodontitis patients, approaching those in healthy individuals. However, this reduction was not statistically significant (P=0.389). In patients with a probing depth (PD) of at least 3 mm, salivary levels of hBD-1 decreased significantly (P=0.019) following the intervention. There was no significant correlation between changes in hBD-1 levels and clinical indices, such as clinical attachment loss (CAL), probing depth, or bleeding index (BI) (P˃0.05). Conclusion. The current study demonstrated promising results concerning a probable link between hBD-1 and periodontitis. However, more research with sufficiently large sample sizes and more robust study designs is necessary.
format Article
id doaj-art-22896b61a9c44ae194e8faa87f14e421
institution DOAJ
issn 2645-5390
language English
publishDate 2024-05-01
publisher Tabriz University of Medical Sciences
record_format Article
series Journal of Advanced Periodontology and Implant Dentistry
spelling doaj-art-22896b61a9c44ae194e8faa87f14e4212025-08-20T02:50:00ZengTabriz University of Medical SciencesJournal of Advanced Periodontology and Implant Dentistry2645-53902024-05-01161303510.34172/japid.2024.002japid-2293Comparison of salivary beta-defensin-1 levels in patients with periodontitis before and after phase I periodontal therapySomaye Ansari Moghadam0Sina Pishadast1Leila Gholami2Ebrahim Alijani3Alireza Ansari Moghadam4Mahdi Hadilou5Department of Periodontology, Oral and Dental Disease Research Center, Zahedan University of Medical Sciences, Zahedan, IranOral and Dental Disease Research Center, Zahedan University of Medical Sciences, Zahedan, IranDepartment of Oral Biological and Medical Sciences, Faculty of Dentistry, University of British Columbia, Vancouver, CanadaDepartment of Clinical Immunology Research Center, Zahedan University of Medical Sciences, Zahedan, IranDepartment of Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, IranFaculty of Dentistry, Tabriz University of Medical Sciences, Tabriz, IranBackground. This study compared human β-defensin 1 (hBD-1) salivary levels in patients with periodontitis before and after phase I periodontal therapy. Methods. This controlled before-and-after study included 16 patients in the intervention group and 28 participants in the control group. Patients in the intervention group had stage 3 grade B periodontitis with no systemic diseases and had not taken any medications in the last six months. The control group included participants with healthy periodontium. Before and after phase I periodontal therapy, salivary samples were collected from the intervention group. ELISA was used to measure hBD-1 levels. Results. Salivary levels of hBD-1 decreased after phase I periodontal treatment in periodontitis patients, approaching those in healthy individuals. However, this reduction was not statistically significant (P=0.389). In patients with a probing depth (PD) of at least 3 mm, salivary levels of hBD-1 decreased significantly (P=0.019) following the intervention. There was no significant correlation between changes in hBD-1 levels and clinical indices, such as clinical attachment loss (CAL), probing depth, or bleeding index (BI) (P˃0.05). Conclusion. The current study demonstrated promising results concerning a probable link between hBD-1 and periodontitis. However, more research with sufficiently large sample sizes and more robust study designs is necessary.https://japid.tbzmed.ac.ir/PDF/japid-16-30.pdfbeta-defensinschronic periodontitisenzyme-linked immunosorbent assayroot planing
spellingShingle Somaye Ansari Moghadam
Sina Pishadast
Leila Gholami
Ebrahim Alijani
Alireza Ansari Moghadam
Mahdi Hadilou
Comparison of salivary beta-defensin-1 levels in patients with periodontitis before and after phase I periodontal therapy
Journal of Advanced Periodontology and Implant Dentistry
beta-defensins
chronic periodontitis
enzyme-linked immunosorbent assay
root planing
title Comparison of salivary beta-defensin-1 levels in patients with periodontitis before and after phase I periodontal therapy
title_full Comparison of salivary beta-defensin-1 levels in patients with periodontitis before and after phase I periodontal therapy
title_fullStr Comparison of salivary beta-defensin-1 levels in patients with periodontitis before and after phase I periodontal therapy
title_full_unstemmed Comparison of salivary beta-defensin-1 levels in patients with periodontitis before and after phase I periodontal therapy
title_short Comparison of salivary beta-defensin-1 levels in patients with periodontitis before and after phase I periodontal therapy
title_sort comparison of salivary beta defensin 1 levels in patients with periodontitis before and after phase i periodontal therapy
topic beta-defensins
chronic periodontitis
enzyme-linked immunosorbent assay
root planing
url https://japid.tbzmed.ac.ir/PDF/japid-16-30.pdf
work_keys_str_mv AT somayeansarimoghadam comparisonofsalivarybetadefensin1levelsinpatientswithperiodontitisbeforeandafterphaseiperiodontaltherapy
AT sinapishadast comparisonofsalivarybetadefensin1levelsinpatientswithperiodontitisbeforeandafterphaseiperiodontaltherapy
AT leilagholami comparisonofsalivarybetadefensin1levelsinpatientswithperiodontitisbeforeandafterphaseiperiodontaltherapy
AT ebrahimalijani comparisonofsalivarybetadefensin1levelsinpatientswithperiodontitisbeforeandafterphaseiperiodontaltherapy
AT alirezaansarimoghadam comparisonofsalivarybetadefensin1levelsinpatientswithperiodontitisbeforeandafterphaseiperiodontaltherapy
AT mahdihadilou comparisonofsalivarybetadefensin1levelsinpatientswithperiodontitisbeforeandafterphaseiperiodontaltherapy